Gilead Beats Street 2q Forecasts On Surge In Sales, Profit

Blockbuster hepatitis C medicine Harvoni lifted Gilead Sciences' second-quarter profit by 23 percent as total revenue for the biotech drugmaker jumped 26 percent and it raised its 2015 sales forecast for the second time.

Topics:  harvoni   gilead sciences   sales   profit   percent   
BING NEWS:
  • Tesla shares surge as second-quarter deliveries beat Wall Street expectations
    The company delivered a total of 443,956 cars – a figure that marked a 4.8% decline from the same period one year ago. However, deliveries were still better than the consensus estimate of 439,000, ...
    07/2/2024 - 8:42 am | View Link
  • Tesla Shares Rise as 2Q Sales Beat Market Expectations
    Wedbush analyst Daniel Ives said the results represented "a huge comeback performance" as Wall Street was expecting the company to miss sales expectations and EV demand is still choppy globally. The ...
    07/2/2024 - 7:56 am | View Link
  • Nikola 2Q Sales Beat Management Expectations
    Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
    07/2/2024 - 1:46 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News